Literature DB >> 36260598

Observational study of factors associated with morbidity and mortality from COVID-19 in Lebanon, 2020-2021.

Moni Nader1, Omar Zmerli2, Daniel E Platt3, Hamdan Hamdan1, Salwa Hamdash4, Rami Abi Tayeh2, Jad Azar2, Diana Kadi2, Youssef Sultan2, Taha Bazarbachi4, Gilbert Karayakoupoglou4, Pierre Zalloua1,5, Eid Azar2.   

Abstract

BACKGROUND: The COVID-19 pandemic claimed millions of lives worldwide without clear signs of abating despite several mitigation efforts and vaccination campaigns. There have been tremendous interests in understanding the etiology of the disease particularly in what makes it severe and fatal in certain patients. Studies have shown that COVID-19 patients with kidney injury on admission were more likely to develop severe disease, and acute kidney disease was associated with high mortality in COVID-19 hospitalized patients.
METHODS: This study investigated 819 COVID-19 patients admitted between January 2020-April 2021 to the COVID-19 ward at a tertiary care center in Lebanon and evaluated their vital signs and biomarkers while probing for two main outcomes: intubation and fatality. Logistic and Cox regressions were performed to investigate the association between clinical and metabolic variables and disease outcomes, mainly intubation and mortality. Times were defined in terms of admission and discharge/fatality for COVID-19, with no other exclusions.
RESULTS: Regression analysis revealed that the following are independent risk factors for both intubation and fatality respectively: diabetes (p = 0.021 and p = 0.04), being overweight (p = 0.021 and p = 0.072), chronic kidney disease (p = 0.045 and p = 0.001), and gender (p = 0.016 and p = 0.114). Further, shortness of breath (p<0.001), age (p<0.001) and being overweight (p = 0.014) associated with intubation, while fatality with shortness of breath (p<0.001) in our group of patients. Elevated level of serum creatinine was the highest factor associated with fatality (p = 0.002), while both white blood count (p<0.001) and serum glutamic-oxaloacetic transaminase levels (p<0.001) emerged as independent risk factors for intubation.
CONCLUSIONS: Collectively our data show that high creatinine levels were significantly associated with fatality in our COVID-19 study patients, underscoring the importance of kidney function as a main modulator of SARS-CoV-2 morbidity and favor a careful and proactive management of patients with elevated creatinine levels on admission.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36260598      PMCID: PMC9581355          DOI: 10.1371/journal.pone.0275101

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


  39 in total

1.  Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis.

Authors:  Giuseppe Lippi; Johnny Wong; Brandon M Henry
Journal:  Pol Arch Intern Med       Date:  2020-03-31

2.  Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China.

Authors:  Hua Su; Ming Yang; Cheng Wan; Li-Xia Yi; Fang Tang; Hong-Yan Zhu; Fan Yi; Hai-Chun Yang; Agnes B Fogo; Xiu Nie; Chun Zhang
Journal:  Kidney Int       Date:  2020-04-09       Impact factor: 10.612

3.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

4.  The clinical course and its correlated immune status in COVID-19 pneumonia.

Authors:  Ruyuan He; Zilong Lu; Lin Zhang; Tao Fan; Rui Xiong; Xiaokang Shen; Haojie Feng; Heng Meng; Weichen Lin; Wenyang Jiang; Qing Geng
Journal:  J Clin Virol       Date:  2020-04-12       Impact factor: 3.168

Review 5.  Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy.

Authors:  Abdulhamid Abdi; Shahad AlOtaiby; Firas Al Badarin; Ali Khraibi; Hamdan Hamdan; Moni Nader
Journal:  Biomed Pharmacother       Date:  2021-12-09       Impact factor: 7.419

Review 6.  Emerging SARS-CoV-2 variants of concern and potential intervention approaches.

Authors:  Jasmin Khateeb; Yuchong Li; Haibo Zhang
Journal:  Crit Care       Date:  2021-07-12       Impact factor: 9.097

7.  Men and COVID-19: A Biopsychosocial Approach to Understanding Sex Differences in Mortality and Recommendations for Practice and Policy Interventions.

Authors:  Derek M Griffith; Garima Sharma; Christopher S Holliday; Okechuku K Enyia; Matthew Valliere; Andrea R Semlow; Elizabeth C Stewart; Roger Scott Blumenthal
Journal:  Prev Chronic Dis       Date:  2020-07-16       Impact factor: 2.830

Review 8.  COVID-19 and liver disease: mechanistic and clinical perspectives.

Authors:  Thomas Marjot; Gwilym J Webb; Alfred S Barritt; Andrew M Moon; Zania Stamataki; Vincent W Wong; Eleanor Barnes
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-03-10       Impact factor: 73.082

9.  In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain.

Authors:  Inés Suárez-García; Isabel Perales-Fraile; Andrés González-García; Arturo Muñoz-Blanco; Luis Manzano; Martín Fabregate; Jesús Díez-Manglano; Eva Fonseca Aizpuru; Francisco Arnalich Fernández; Alejandra García García; Ricardo Gómez-Huelgas; José-Manuel Ramos-Rincón
Journal:  PLoS One       Date:  2021-08-03       Impact factor: 3.240

Review 10.  Covid-19 and kidney injury: Pathophysiology and molecular mechanisms.

Authors:  Elham Ahmadian; Seyed Mahdi Hosseiniyan Khatibi; Saiedeh Razi Soofiyani; Sima Abediazar; Mohammadali M Shoja; Mohammadreza Ardalan; Sepideh Zununi Vahed
Journal:  Rev Med Virol       Date:  2020-10-06       Impact factor: 11.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.